We are thrilled to announce we are part of the ten finalists for the Lyfebulb Helsinn 2019 Innovation Summit in Oncology taking place in Monaco on March 18-19. This is the recognition of the excellence of our programs and their potential benefits for patients suffering of cancer.
Lyfebulb is a patient empowerment platform that connects patients, industry and investors to support user-driven innovation toward solutions in chronic disease, and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care.
Lyfebulb Helsinn Press Release is available here
More information on the event is available here